Many view the promise of stem cells as something far off in the distance, but these regenerative cells are nearing commercialization in the area of cosmetic and plastic surgery, particularly for women who are in need of reconstructive breast surgery. Dr. Marc Hedrick, president of San Diego based Cytori Therapeutics, tells the Chicago Tribune's Bruce Japsen about a commercialized device in Europe that uses adult stem cells derived from fat as a way to reconstruct breasts following surgery. Clinical trials may begin in the US in the next year.